FRA/GIS (FRA/GIS)

Frankfurt Stock Exchange: FRA/GIS · EUR

€141

-0.54 (-0.4%)· Recorded snapshot

Market cap	177B
Revenue (ttm)	26.7B
Net income (ttm)	-2.8B
EPS (ttm)	-€2.35
P/E (forward)	18.7x
Dividend	€2.80 (1.98%)
Volume	4

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 26.7B
Net income (ttm): -2.8B
EPS (ttm): -€2.35
P/E (forward): 18.7x
Market cap: 177B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18.7

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-20.7

P25 n/aP50 n/aP75 n/a

ROIC34.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All FRA/GIS indicators

Market & fundamental data

Available fields

236

Groups with data

Currency

USD

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-10-29
Employees	17,000
Employees change	-400
Employees growth	-2.22%
Enterprise value	EUR 196.1B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1987
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US3755581036
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split date	2013-01-28
Last stock split type	Forward
Market cap	EUR 177B
Next earnings date	2026-10-29
Price	EUR 141.32
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	fra/GIS
Website	https://www.gilead.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	75.16x
Average P/E ratio (3Y)	133.64x
Average P/E ratio (5Y)	84.97x
Earnings yield	-1.66%
EV/EBIT	18.46x
EV/EBITDA	14.8x
EV/FCF	17.31x
EV/Sales	7.18x
FCF / EV yield	5.78%
FCF yield	6.4%
Forward P/E	18.73x
P/(FCF - SBC) ratio	16.81x
P/(OCF - SBC) ratio	16x
P/B ratio	17.22x
P/FCF ratio	15.63x
P/OCF ratio	14.92x
P/S ratio	6.64x
Price/EBITDA ratio	13.85x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	38.88%
EBITDA margin	47.94%
FCF margin	41.4%
Gross margin	79.6%
Operating margin	38.88%
Pretax margin	-6.42%
Profit margin	-10.64%
Profit per employee	EUR -166,822
Profitable years	19
Revenue per employee	EUR 1.6M
ROA	14.09%
ROA (5Y)	10.85%
ROCE	30.88%
ROE	-20.68%
ROE (5Y)	24.33%
ROIC	34.37%
ROIC (5Y)	21.93%
SBC / revenue	2.98%
Tax / revenue	4.22%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
FCF growth	38.15%
FCF growth (Q)	376.81%
FCF growth (QoQ)	41.45%
FCF growth 3Y	13.19%
FCF growth 5Y	8.85%
Gross profit growth	6.96%
Gross profit growth (Q)	11.52%
Gross profit growth 3Y	3.69%
Gross profit growth 5Y	1.75%
Net income growth years	1
OCF growth	37.33%
OCF growth (Q)	332.04%
OCF growth (QoQ)	40.45%
OCF growth 10Y	-2.84%
OCF growth 3Y	12.52%
OCF growth 5Y	8.31%
Operating income growth	7.34%
Operating income growth (Q)	-5.23%
Operating income growth 3Y	6.62%
Operating income growth 5Y	-1.1%
Revenue growth	5.52%
Revenue growth (Q)	10.18%
Revenue growth (QoQ)	12.11%
Revenue growth 10Y	-0.61%
Revenue growth 3Y	3.61%
Revenue growth 5Y	2.72%
Revenue growth quarters	5
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -533.1M
Depreciation and amortization	EUR 2.5B
EBIT	EUR 10.4B
EBITDA	EUR 12.8B
EPS	EUR -2.35
Financing cash flow	EUR -4.1B
Free cash flow	EUR 11.3B
Free cash flow minus SBC	EUR 10.5B
Gross profit	EUR 21.2B
Income taxes	EUR 1.1B
Investing cash flow	EUR -9.5B
Net borrowing	EUR 1.2B
Net cash flow	EUR -1.7B
Net income	EUR -2.8B
Operating cash flow minus SBC	EUR 11.1B
Operating income	EUR 10.4B
Revenue	EUR 26.7B
Stock-based compensation	EUR 795.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.05
Book value per share	EUR 8.34
Debt / EBITDA	1.78
Debt / equity	2.23
Debt / FCF	2.03
Goodwill	EUR 7.5B
Interest coverage	11.86
Long-term assets	EUR 30.7B
Long-term liabilities	EUR 23B
Net cash (debt)	EUR -18.7B
Net cash / market cap	-10.56%
Net debt / EBITDA	1.46
Net debt / equity	1.82
Net debt / FCF	1.65
Piotroski F-Score	5
Property, plant and equipment	EUR 5.2B
Shareholders' equity	EUR 10.3B
Tangible book value	EUR -9.2B
Tangible book value per share	EUR -7.42
Total assets	EUR 43.2B
Total cash	EUR 4.3B
Total debt	EUR 23B
Total liabilities	EUR 32.9B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.58
Current assets	EUR 12.5B
Current liabilities	EUR 9.9B
Current ratio	1.27
Inventory turnover	3.29
Net working capital	EUR 400M
Quick ratio	0.9
Working capital	EUR 2.6B
Working capital turnover	8.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.39%
Dividend growth	-0.53%
Dividend growth (10Y)	5.7%
Dividend growth (3Y)	0.31%
Dividend growth (5Y)	3.65%
Dividend growth years	0
Dividend payment date	2026-09-29
Dividend payment years	12
Dividend payout frequency	Quarterly
Dividend per share	EUR 2.80
Dividend yield	1.98%
Ex-dividend date	2026-09-15
Last dividend	EUR 0.71
Shareholder yield	3.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	103.93%
10Y return CAGR	11.25%
10Y total return	190.37%
150-day SMA	EUR 119.75
15Y price change	851.65%
15Y return CAGR	19.2%
15Y total return	1,294.02%
1D price change	-0.38%
1M price change	7.73%
1M total return	7.73%
1W price change	2.11%
1W total return	2.11%
1Y price change	36.54%
1Y return CAGR	39.94%
1Y total return	39.91%
20-day SMA	EUR 135.33
200-day SMA	EUR 120.51
3M price change	23.49%
3M total return	24.2%
3Y price change	90.61%
3Y return CAGR	27.96%
3Y total return	109.54%
50-day SMA	EUR 130.93
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 142.00
52-week high date	2026-10-15
52-week low	EUR 97.79
52-week low date	2025-10-30
5Y price change	139.97%
5Y return CAGR	23.45%
5Y total return	186.73%
6M price change	26.16%
6M total return	27.71%
All-time high	EUR 142.00
All-time high date	2026-10-15
All-time low	EUR 12.45
All-time low date	2011-08-11
Average true range (ATR)	EUR 2.04
Average volume	152.9
Change from 52-week high	-0.48%
Change from 52-week low	44.51%
Change from all-time high	-0.48%
Change from all-time low	1,035.56%
Change from open	-0.18%
Day's gap	-0.2%
Dollar volume	EUR 565
High price	EUR 141.58
Low price	EUR 141.32
Monthly RSI	71.06
Open price	EUR 141.58
Position in 52-week range	0%
Previous close	EUR 141.86
Price vs 150-day SMA	18.01%
Price vs 20-day SMA	4.42%
Price vs 200-day SMA	17.27%
Price vs 50-day SMA	7.94%
Relative volume	0.03
RSI	66.84
Sharpe ratio	1.24
Sharpe ratio (3Y)	0.86
Sharpe ratio (5Y)	0.78
Sortino ratio	2.21
Sortino ratio (3Y)	1.58
Sortino ratio (5Y)	1.5
Volume	4
Weekly RSI	71.5
YTD price change	33.75%
YTD total return	36.17%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.2B
Shares change (QoQ)	-0.88%
Shares change (YoY)	-1.39%
Shares held by insiders	0.09%
Shares held by institutions	90.91%
Short ratio	3.3 days

Deeper analysis on FRA/GIS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this FRA/GIS report

Is a complete FRA/GIS research report available?

No complete published report is available for fra/GIS (FRA/GIS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

FRA/GIS (FRA/GIS)

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/GIS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/GIS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on FRA/GIS

Frequently asked questions